FMR LLC 13D and 13G filings for Syros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-04-11 09:01 am Sale | 2022-04-08 | 13G | Syros Pharmaceuticals, Inc. SYRS | FMR LLC | 579,788 9.298% | -353,492 (-37.88%) | Filing |
| 2022-02-09 10:01 am Purchase | 2022-02-08 | 13G | Syros Pharmaceuticals, Inc. SYRS | FMR LLC | 933,280 14.999% | 242,046 (+35.02%) | Filing |
| 2021-02-08 10:33 am Purchase | 2021-02-05 | 13G | Syros Pharmaceuticals, Inc. SYRS | FMR LLC | 691,234 14.999% | 50,543 (+7.89%) | Filing |